
The prevalence of Crohn's disease (CD), a chronic and life-threatening inflammatory bowel disease (IBD), is steadily increasing worldwide. A shift to personalized medicine is required because CD is a very heterogeneous disease that poses ongoing challenges in prognosis and treatment...